The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guerin (BCG)

British Journal of Pharmacology

Volumn 120, Issue 3, 1997, Pages 502-508

  Campos, Maria M ^a   Henriques, Maria G M O ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Department of Applied Pharmacology   (Brazil)

Author keywords

B1 and B2 agonists and antagonists; BCG; Dexamethasone; Indomethacin; Paw oedema (rat)

Indexed keywords

BCG VACCINE; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ DERIVATIVE; DEXAMETHASONE; INDOMETACIN; KALLIDIN DERIVATIVE; ANTIINFLAMMATORY AGENT; BRADYKININ RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; BRADYKININ, TYR(8); BRADYKININ, TYR(8)-; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG POTENTIATION; EDEMA; FOOT; INTRADERMAL DRUG ADMINISTRATION; MYCOBACTERIOSIS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; DEXAMETHASONE; EDEMA; FOOT; INDOMETHACIN; INJECTIONS, INTRADERMAL; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ;

EID: 0030614467     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700914     Document Type: Article

References (37)

1. 1 receptors in the polymorphonuclear leucocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol., 156, 269-274.
2. BATHON, J.M., MANNING, D.C., GOLDMAN, D.W., TOWNS, M.C. & PROUD, D. (1992). Regulation of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Pharmacol. Exp. Ther., 260, 384-392.
3. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Biorregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 1-80.
4. BOHLE, A., NOWC, C., ULMER, A.J., MUSEHOLD, J., GERDES, J., HOFSTETTER, A.G. & FLAD, H.D. (1990). Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy. J. Urol., 144, 59-64.
5. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257-264.
6. 2 in 3T3 fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 85, 6306-6309.
7. BURCH, R.M., CONNOR, J.R. & TIFFANY, C.W. (1989a). The kallikrein-kininogen-kinin system in chronic inflammation. Agents Actions, 27, 258-260.
8. BURCH, R.M., KYLE, D.J. & STORMENN, T.M. (1993). Molecular Biology and Pharmacology of Bradykinin Receptors, ed. Burch, R.M., pp. 107, Austin: R.G. Landes Co.
9. BURCH, R.M. & TIFFANY, C.W. (1989). Tumor necrosis factor amplification of arachidonic acid metabolism in responses to interleukin-1, bradykinin, and other agonists. J. Cell. Physiol., 141, 85-89.
10. BURCH, R.M., WHITE, M.F. & CONNOR, J.R. (1989b). Interleukin-1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interaction between two second messenger systems. J. Cell. Physiol., 139, 29-33.
11. CABRINI, D.A., KYLE, D.J. & CALIXTO, J.B. (1996). A pharmacological analysis of receptor subtypes and the mechanisms mediating the biphasic response induced by kinins in the rat stomach fundus in vitro. J. Pharmacol. Exp. Ther., 277, 299-307.
12. 2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol., 114, 1005-1013.
13. 1 receptors mediating paw oedema and formalin induced-nociception. Modulation by glucocorticoids. Can. J. Physiol. Pharmacol., 73, 812-819.
14. 9-bradykinin-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol., 117, 793-798.
15. CENTERS FOR DISEASE CONTROL AND PREVENTION. RECOMMENDATION OF THE IMMUNIZATION PRACTICES ADVISORY COMMITTEE (ACIP). (1988). A joint statement by the ACIP and the Advisory Committee for elimination of tuberculosis. MMWR, 37, 669-675.
16. COLDITZ, G.A., BREWER, T.F., BERKEY, C.S., WILSON, M.E., BURDICK, E., FINEBERG, H.V., MOSTLLER, F. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA., 271, 698-702.
17. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol., 110, 193-198.
18. 9-Bradykinin. Br. J. Pharmacol., 93, 969-977.
19. 9-bradykinin: possible role of interleukin-1. Br. J. Pharmacol., 103, 314-315.
20. DEREIJKE, T.M., VOS, P.C., DEBOER, E.C., BEVERS, R.F., DEMUIN-KAISER, W.H., KURTH, K.H. & SHAMHART, D.H. (1993). Cytokine production by human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol. Res., 21, 349-352.
21. DRAY, A. & PERKINS, M.N. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99-104.
22. FARMER, S.G. & BURCH, R.M. (1992). Biochemical and molecular pharmacology of kinin receptors. Ann. Rev. Pharmacol. Toxicol., 32, 511-532.
23. FERREIRA, S.H., LORENZETTI, B.B. & POOLE, S. (1993). Bradykinin initiates cytokine inflammatory hyperalgesia. Br. J. Pharmacol., 110, 1227-1231.
24. FINE, P.E.M. (1995). Variation in protection by BCG: implications of and for heterologous immunity. Lancet, 346, 1339-1345.
25. GAGINELLA, T.S. & KACHUR, J.F. (1989). Kinin mediators of intestinal secretion. Am. J. Physiol., 256, G1-G15.
26. HALL, J.M. (1992). Bradykinin receptors pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
27. HESS, J.F., BORKOWSKI, J.A., MACNEIL, T., STONESIFER, G.Y., FRAHER, J., STRADER, C.D. & RANSOM, R.W. (1994). Differential pharmacology of cloned human and mouse B2 bradykinin receptors. Mol. Pharmacol., 45, 1-8.
28. 2 receptor. Biochem. Biophys. Res. Commun., 184, 260-268.
29. 1 receptors: a review. Immunopharmacology, 30, 1-26.
30. MARCEAU, F., LUSSIER, A., REGOLI, D. & GIROUD, J.P. (1983). Pharmacology of kinins; their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209-229.
31. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A., 88, 7724-7728.
32. 1 bradykinin receptor. J. Biol. Chem., 269, 21583-21586.
33. 8]-bradykinin and Hoe 140, into two models of persistent hyperalgesia in the rat. Pain, 53, 191-197.
34. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol., 110, 1441-1444.
35. 1 receptor gene. Biochem. Biophys., 220, 219-225.
36. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
37. TIFFANY, C.W. & BURCH, R.M. (1989). Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett., 247, 189-192.